Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aesthetic Medical International Holdings Group is a China-based operator of medical aesthetics hospitals and clinics, providing surgical aesthetic procedures, non-surgical aesthetic treatments, and certain general healthcare services. Its offerings include surgical procedures such as eyelid surgery, rhinoplasty, breast augmentation, liposuction, and facelifts, as well as minimally invasive and energy-based treatments using technologies such as laser, ultrasound, and radiofrequency. The company also provides selected ancillary healthcare services including dentistry, dermatology, obstetrics and gynecology, internal medicine, and hair-loss-related services. The business is organized as a Cayman Islands holding company with operating subsidiaries in China and has historically been listed in the U.S. through ADSs. For a biotech analyst, this is best characterized as a commercial healthcare services and medical aesthetics delivery company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aesthetic Medical International Holdings Group.